The DOI matches its Crossref record; 27 of the 30 references it cites were found in a registry or an index.
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
Open accessAbstract
Background Psoriasis and atopic dermatitis (AD) are common inflammatory skin diseases. An upregulated TH17/IL-23 pathway was demonstrated in psoriasis. Although potential involvement of TH17 T cells in AD was suggested during acute disease, the role of these cells in chronic AD remains unclear.Objective To examine differences in IL-23/TH17 signal between these diseases and establish relative frequencies of T-cell subsets in AD.Methods Skin biopsies and peripheral blood were collected from patients with chronic AD (n = 12) and psoriasis (n = 13). Relative frequencies of CD4+ and CD8+ T-cell subsets within these 2 compartments were examined by intracellular cytokine staining and flow cytometry.Results In peripheral blood, no significant difference was found in percentages of different T-cell subsets between these diseases. In contrast, psoriatic skin had significantly increased frequencies of TH1 and TH17 T cells compared with AD, whereas TH2 T cells were significantly elevated in AD. Distinct IL-22-producing CD4+ and CD8+ T-cell populations were significantly increased in AD skin compared with psoriasis. IL-22+CD8+ T-cell frequency correlated with AD disease severity.Conclusion Our data established that T cells could independently express IL-22 even with low expression levels of IL-17. This argues for a functional specialization of T cells such that "T17" and "T22" T-cells may drive different features of epidermal pathology in inflammatory skin diseases, including induction of antimicrobial peptides for "T17" T cells and epidermal hyperplasia for "T22" T-cells. Given the clinical correlation with disease severity, further characterization of "T22" T cells is warranted, and may have future therapeutic implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Circulating IL-22 correlates with the severity of AD and appears as a key driver in the inflammatory reaction116,119.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [116]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-22 is an important part of the transcriptomic signature in AD116,117.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
The skin: an indispensable barrier
Proksch, E., Brandner, J. M., & Jensen, J. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00786.x · Cited by 2,054
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P. A., Kasman, I. M., Eastham‐Anderson, J., Wu, J., & Ouyang, W. (2006) · Nature · doi:10.1038/nature05505 · Cited by 1,886
Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
Lowes, M. A., Kikuchi, T., Fuentes‐Duculan, J., Cardinale, I. R., Zaba, L. C., Haider, A. S., Bowman, E. P., & Krueger, J. G. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701213 · Cited by 1,085
Self-citationCytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Boniface, K., Bernard, F.-X., Garcia, M., Gurney, A. L., Lecron, J.-C., & Morel, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3695 · Cited by 864
Nograles, K. E., Zaba, L. C., Guttman‐Yassky, E., Fuentes‐Duculan, J., Suárez‐Fariñas, M., Cardinale, I. R., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., et al. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08769.x · Cited by 816
Self-citationPossible Pathogenic Role of Th17 Cells for Atopic Dermatitis
Koga, C., Kabashima, K., Shiraishi, N., Kobayashi, M., & TOKURA, Y. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.111 · Cited by 680
Ma, H., Liang, S. C., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M., Gill, D. S., Dunussi‐Joannopoulos, K., Collins, M. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33263 · Cited by 555
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Flagged first, then by citations
3 of the 30 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–626 of 626
Ramos, Y. Á. L., Pietrobon, A. J., Teixeira, F. M. E., Aoki, V., Sato, M. N., & Orfali, R. L. (2025) · Anais Brasileiros de Dermatologia (Versão em Português) · doi:10.1016/j.abdp.2025.501136
Алгоритмы планирования передачи данных от космических аппаратов на наземные станции
Pavlov, D., Kodukov, A., & Субботин, М. О. (2025) · Computer Tools in Education · doi:10.32603/2071-2340-2025-1-108-117
Multi-omic triangulation identifies molecular candidates of atopic dermatitis severityPreprint
Watts, K., Hübenthal, M., Szymczak, S., Cherry, H., Xing, H., Federico, A., Lopata, O., Acencio, M. L., Hofner, M., Lessard, S., et al. (2025) · medRxiv · doi:10.1101/2025.08.04.25332125
Tian, T., Wang, N., Jing, F., Wang, N., Zhi, W., Zhu, X., & Liu, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115880
Cellular immunology of preterm labor and birth and its potential utility for biomarker discovery
Gomez‐Lopez, N., Levenson, D., Lee, S., Neshek, B., & Galaz, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-21564-3.00020-9
Buddenkotte, J., Ahmad, F., Chang, J., Al‐Khawaga, S., Wang, F., Meng, J., & Steinhoff, M. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34172-4.00024-0
Yahia, S. A. (2012) · theses.fr (ABES) · doi:10.70675/6de648e7z3279z4874z8987zdfd0f3013593
“Elles ont été décrites dans les maladies cutanées notamment la dermatite atopique [158].”
BackgroundZimmer, A. (2011) · theses.fr (ABES) · doi:10.70675/7c52785dzf817z4454zbc7dzf6abef8d371d
“Une nouvelle population de LTs appelés Th22 et secr étant de l’IL-22 en présence de faibles concentrations d’IL-17 a également montré son rôle dans les maladies allergiques, en particulier la dermatite atopique [46].”
BackgroundCD28 : nouvelles données sur un récepteur majeur de la costimulation lymphocytaire T
Morin, S. O. (2017) · theses.fr (ABES) · doi:10.70675/cb01635fz2f63z43e2zad0cz210485c4c5cf
Rôle de l'oncostatine M et des interleukines 6 et 31 dans l'inflammation cutanée chez la souris
Pohin, M. (2017) · theses.fr (ABES) · doi:10.70675/6ee5de11z33c0z4d68z9887z2c7a7194291a
Reconstitution in vitro des réponses immunitaires initiales dans la dermatite atopique
Brulefert, A. (2020) · theses.fr (ABES) · doi:10.70675/4f0faf3cz1452z496dz8fe2z3a669eab038a
Chen, N., Zhuo, Q., Luo, M., Lin, J., Zhang, H., Li, R., & Han, Y. (2026) · Dermatologic Therapy · doi:10.1155/dth/8700134
Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety
Masoumi, N., Monadi, T., Aminzade, Z., Soltani, A., Noqani, H., & Enderami, S. E. (2026) · Current Therapeutic Research · doi:10.1016/j.curtheres.2026.100833
“121 , 122 Fezakinumab was initially designed to treat psoriasis and rheumatoid arthritis.”
Işık, L., Gönül, M., Kartal, S. P., & GÜÇEL, F. (2026) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1603a7150
Microbiome and Gut Immunity: T Cells
Palatella, M., Wagner, S., Busch, D. H., & Huehn, J. (2026) · Springer eBooks · doi:10.1007/978-3-032-26410-7_9
Lee, J., Chun, Y. S., Nam, H. J., Huh, Y. J., Kim, J., Krueger, J. G., Paik, S. S., Kim, H. J., Jin, S., & Kim, J. (2026) · Allergy · doi:10.1111/all.70526
Self-citationHazlianda, C. P., Pane, Y. S., Lubis, R. D. S., Rambe, A. Y. M., Djawad, K., Laksmi, L. I., Amin, M. M., & Restimulia, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1883375
“IL-22 is secreted by Th22, Th17, and ILC3 cells, with Th22 cells serving as the main source in AD (11, 15).”
Luca, E. D., Campanati, A., Galluzzo, M., Gori, N., Megna, M., Napolitano, M., Rech, G., & Caldarola, G. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01950-4
Zhang, L., Meng, Z., Bo, H., Tian, Y., 牟伟才, Ping, X., Dong, J., & Li, Y. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.11.758381
Maiga, B. (2014) · DiVA (Stockholm University)
Host and environmental contribution to atopic dermatitis in dogs
van Beeck, F. A. L. (2014) · Utrecht University Repository (Utrecht University)
Metadata
- Authors
- Nograles, K. E., Zaba, L. C., Shemer, A., Fuentes-Duculan, J., Cardinale, I., Kikuchi, T., Ramon, M., Bergman, R., Krueger, J. G., & Guttman-Yassky, E.
- Affiliations
- Rockefeller University (US)
- Technion – Israel Institute of Technology (IL)
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 123
- Issue
- 6
- Pages
- 1244-1252.e2
- ISSN
- 0091-6749 (ISSN-L)
- PMC
- PMC2874584
- OpenAlex
- W2164098277
- Cited by
- 627
- References
- 30
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 21 · 2023: 23 · 2022: 28 · 2021: 39 · 2020: 39 · 2019: 28 · 2018: 25 · 2017: 49 · 2016: 49 · 2015: 51 · 2014: 52 · 2013: 34 · 2012: 47
- FWCI
- 65.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Allergy and Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM 07739, T32GM007739)
- National Center for Research Resources (UL1RR024143)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- atopic dermatitis, IL-22, IL-17, Th17 cells, Th2 cells, Th1 cells, IL-23, psoriasis, CD4+ T cells, CD8+ T cells, disease severity, epidermal hyperplasia, antimicrobial peptides, skin inflammation
- MeSH terms
- Interleukin-22, Adult, Chronic Disease, Dermatitis, Atopic, T-Lymphocytes, Helper-Inducer, Humans, Interleukins, Middle Aged, Psoriasis, T-Lymphocyte Subsets, Interleukin-17, Interleukin-23
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review